NO2480560T3 - - Google Patents
Info
- Publication number
- NO2480560T3 NO2480560T3 NO10818191A NO10818191A NO2480560T3 NO 2480560 T3 NO2480560 T3 NO 2480560T3 NO 10818191 A NO10818191 A NO 10818191A NO 10818191 A NO10818191 A NO 10818191A NO 2480560 T3 NO2480560 T3 NO 2480560T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8203—Virus mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16123—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24478609P | 2009-09-22 | 2009-09-22 | |
| PCT/CA2010/001489 WO2011035423A1 (en) | 2009-09-22 | 2010-09-21 | Method of preparing plant-derived proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2480560T3 true NO2480560T3 (pt) | 2018-07-21 |
Family
ID=43795254
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO10818190A NO2480658T3 (pt) | 2009-09-22 | 2010-09-21 | |
| NO10818191A NO2480560T3 (pt) | 2009-09-22 | 2010-09-21 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO10818190A NO2480658T3 (pt) | 2009-09-22 | 2010-09-21 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US11833200B2 (pt) |
| EP (3) | EP2480658B1 (pt) |
| JP (2) | JP5554414B2 (pt) |
| KR (4) | KR101773431B1 (pt) |
| CN (4) | CN107129973A (pt) |
| AR (2) | AR078432A1 (pt) |
| AU (2) | AU2010300033B2 (pt) |
| BR (2) | BR112012006414B1 (pt) |
| CA (2) | CA2772964C (pt) |
| DK (3) | DK2480560T3 (pt) |
| ES (3) | ES2642631T3 (pt) |
| HR (3) | HRP20220478T1 (pt) |
| HU (3) | HUE036776T2 (pt) |
| IL (4) | IL218393A0 (pt) |
| IN (2) | IN2012DN02637A (pt) |
| MX (2) | MX2012003373A (pt) |
| MY (2) | MY164704A (pt) |
| NO (2) | NO2480658T3 (pt) |
| NZ (2) | NZ598508A (pt) |
| PL (3) | PL2480658T3 (pt) |
| PT (3) | PT3354657T (pt) |
| RU (2) | RU2567012C2 (pt) |
| SG (2) | SG178947A1 (pt) |
| SI (3) | SI2480560T1 (pt) |
| TR (1) | TR201803560T4 (pt) |
| WO (2) | WO2011035422A1 (pt) |
| ZA (2) | ZA201202836B (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
| CN101978066A (zh) | 2007-11-27 | 2011-02-16 | 麦迪卡格公司 | 表达血凝素之转基因植物中生产的重组流感病毒样颗粒(vlp) |
| NZ597401A (en) | 2009-06-24 | 2013-09-27 | Medicago Inc | Chimeric influenza virus-like particles comprising hemagglutinin |
| PL2480658T3 (pl) * | 2009-09-22 | 2017-12-29 | Medicago Inc. | Sposób otrzymywania VLP pochodzenia roślinnego |
| TWI526539B (zh) | 2010-12-22 | 2016-03-21 | 苜蓿股份有限公司 | 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp |
| TWI620816B (zh) | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
| JP6297488B2 (ja) * | 2011-06-13 | 2018-03-20 | メディカゴ インコーポレイテッド | 植物中での狂犬病ウイルス様粒子の生成 |
| US9441019B2 (en) * | 2011-09-23 | 2016-09-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Influenza hemagglutinin protein-based vaccines |
| US11390878B2 (en) | 2011-09-30 | 2022-07-19 | Medicago Inc. | Increasing protein yield in plants |
| TWI700368B (zh) | 2011-09-30 | 2020-08-01 | 苜蓿股份有限公司 | 增加植物類病毒顆粒產率 |
| CN104114696B (zh) * | 2011-12-21 | 2017-05-03 | 阿普斯有限责任公司 | 使用具有对水解酶抗性的衣壳的vlp的方法 |
| JP6406655B2 (ja) * | 2012-02-22 | 2018-10-17 | 三菱商事フードテック株式会社 | 植物性食品素材の軟化方法、軟化製剤、軟化した植物性食品素材およびそれを用いた食品 |
| IN2014DN07152A (pt) * | 2012-03-22 | 2015-04-24 | Fraunhofer Usa Inc | |
| RU2693431C2 (ru) | 2012-09-05 | 2019-07-02 | Медикаго Инк. | Получение пикорнавирусоподобных частиц в растениях |
| US9617297B2 (en) * | 2012-10-11 | 2017-04-11 | The Regents Of The University Of California | Apoplast wash fluid recovery for improved recombinant endoglucanase extraction in tabacco leaves |
| CN105247059B (zh) * | 2013-03-28 | 2021-07-06 | 莫迪卡戈公司 | 植物中流感样病毒颗粒的产生 |
| JP6358257B2 (ja) | 2013-09-06 | 2018-07-18 | 三菱ケミカル株式会社 | 植物を用いたタンパク質の製造方法 |
| EP3906939A1 (en) | 2013-10-11 | 2021-11-10 | The United States of America, represented by the Secretary, Department of Health and Human Services | Epstein-barr virus vaccines |
| US11441150B2 (en) | 2014-01-10 | 2022-09-13 | Medicago Inc. | CPMV enhancer elements |
| RU2731295C2 (ru) | 2014-07-11 | 2020-09-01 | Медикаго Инк. | Модификация продуцирования белков в растениях |
| CN107427571A (zh) | 2014-12-31 | 2017-12-01 | 美利坚合众国,由健康及人类服务部部长代表 | 基于纳米颗粒的新型多价疫苗 |
| JP2019129705A (ja) * | 2016-03-31 | 2019-08-08 | 日本たばこ産業株式会社 | 植物に物質を導入する方法 |
| IL265121B2 (en) | 2016-09-02 | 2023-11-01 | Us Health | Stable group 2 trimers from the stem region of influenza hemagglutinin and their uses |
| MX2020005530A (es) | 2017-11-30 | 2021-01-15 | Medicago Inc | Proteinas vp1 de norovirus modificadas y psv que comprenden proteinas vp1 de norovirus modificadas. |
| CA3103842A1 (en) | 2018-06-27 | 2020-01-02 | Medicago Inc. | Influenza virus hemagglutinin mutants |
| WO2020010428A1 (en) * | 2018-07-13 | 2020-01-16 | Medicago Inc. | Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins |
| CN109112093B (zh) * | 2018-09-05 | 2021-11-09 | 上海交通大学 | 一种青蒿原生质体高效分离及瞬时转化的方法 |
| WO2020219927A1 (en) * | 2019-04-25 | 2020-10-29 | Flagship Pioneering Innovations Vi, Llc | Compositions and methods relating to plant messenger packs |
| CN110483616B (zh) * | 2019-07-31 | 2021-06-04 | 中国农业科学院农产品加工研究所 | 从感染病原菌的植物组织中分离病原菌分泌的质外体效应蛋白的方法 |
| CN111060696B (zh) * | 2019-12-27 | 2023-09-08 | 湖南农业大学 | 一种降低植物小分子信号肽假阳性率的方法 |
| CN111718394A (zh) * | 2020-06-28 | 2020-09-29 | 广西壮族自治区农业科学院 | 一种基于bpp法的甘蔗组织变性蛋白提取方法 |
| CN111826394A (zh) * | 2020-08-07 | 2020-10-27 | 浙江华缔药业集团医药开发有限公司 | 植物瞬时表达载体的构建及应用 |
| WO2022260849A1 (en) | 2021-06-09 | 2022-12-15 | Nant Holdings Ip, Llc | Methods and systems for producing a protein of interest in a plant |
| CN114934007B (zh) * | 2022-07-01 | 2023-11-24 | 广东省农业科学院作物研究所 | 一种甘薯原生质体的制备方法 |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5036006A (en) | 1984-11-13 | 1991-07-30 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
| US5100792A (en) | 1984-11-13 | 1992-03-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues |
| JPS62501263A (ja) | 1984-11-29 | 1987-05-21 | スクリツプス クリニツク アンド リサ−チ フアウンデ−シヨン | 脱グリコシル化ウイルス糖タンパク質に関連するポリペプチド類および抗体 |
| JPS61265086A (ja) * | 1985-05-21 | 1986-11-22 | Mitsui Toatsu Chem Inc | プロトプラストの培養法 |
| US5232833A (en) | 1988-09-14 | 1993-08-03 | Stressgen Biotechnologies Corporation | Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants |
| US6403865B1 (en) | 1990-08-24 | 2002-06-11 | Syngenta Investment Corp. | Method of producing transgenic maize using direct transformation of commercially important genotypes |
| EP0509656B1 (en) | 1991-03-28 | 1996-09-18 | Rooperol (Na) Nv | Compositions of phytosterols and phytosterolins as immunmodulators |
| UA48104C2 (uk) | 1991-10-04 | 2002-08-15 | Новартіс Аг | Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника |
| US6326470B1 (en) * | 1997-04-15 | 2001-12-04 | The Penn State Research Foundation | Enhancement of accessibility of cellulose by expansins |
| US5762939A (en) | 1993-09-13 | 1998-06-09 | Mg-Pmc, Llc | Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
| GB9414118D0 (en) | 1994-07-13 | 1994-08-31 | Axis Genetics Ltd | Modified plant viruses as vectors of heterologous peptides |
| US6020169A (en) * | 1995-07-20 | 2000-02-01 | Washington State University Research Foundation | Production of secreted foreign polypeptides in plant cell culture |
| US5773695A (en) * | 1996-01-26 | 1998-06-30 | North Carolina State University | Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells |
| US6042832A (en) | 1996-08-28 | 2000-03-28 | Thomas Jefferson University | Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins |
| US20010006950A1 (en) | 1998-02-11 | 2001-07-05 | Juha Punnonen | Genetic vaccine vector engineering |
| US6489537B1 (en) | 1998-08-07 | 2002-12-03 | The Trustees Of The University Of Pennsylvania | Phytochelatin synthases and uses therefor |
| MXPA01001445A (es) | 1998-08-11 | 2002-11-29 | Large Scale Biology Corp | Metodo para recuperar proteinas a partir del fluido intersticial de tejidos de plantas. |
| US6287570B1 (en) | 1998-11-23 | 2001-09-11 | Patricia L. Foley | Vaccine against swine influenza virus |
| WO2000037663A2 (en) | 1998-12-23 | 2000-06-29 | The Samuel Roberts Noble Foundation, Inc. | Plant transformation process |
| FR2791358B1 (fr) | 1999-03-22 | 2003-05-16 | Meristem Therapeutics | Promoteurs chimeriques d'expression, cassettes d'expression, plasmides, vecteurs, plantes et semences transgeniques les contenant et leurs methodes d'obtention |
| AU4365200A (en) | 1999-04-21 | 2000-11-02 | Samuel Roberts Noble Foundation, Inc., The | Plant transformation process |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| EP1310551A4 (en) * | 2000-08-08 | 2004-09-22 | Kitasato Inst | VIRUS-LIKE MICROBALLS AND METHOD FOR THEIR PRODUCTION (02/15/02) |
| DK1362109T3 (da) | 2001-01-18 | 2009-07-27 | Vlaams Interuniv Inst Biotech | Rekombinante oligomere protein-komplekser med foröget immunogent potentiale |
| US20050037420A1 (en) | 2001-09-14 | 2005-02-17 | Mei-Yun Zhang | Immunoglobulin having particular framework scaffold and methods of making and using |
| CN103540614B (zh) | 2002-02-13 | 2018-02-02 | 威斯康星旧生研究基金会 | 包装流感病毒载体的信号 |
| US20040063188A1 (en) | 2002-02-14 | 2004-04-01 | Novavax, Inc. | Kit for treating gastrointestinal tract |
| EP2319935B1 (en) | 2002-03-19 | 2016-04-27 | Stichting Dienst Landbouwkundig Onderzoek | GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants. |
| CA2524293A1 (en) | 2003-05-05 | 2004-11-18 | Boyce Thompson Institute For Plant Research | Vectors and cells for preparing immunoprotective compositions derived from transgenic plants |
| KR20060029214A (ko) | 2003-05-05 | 2006-04-05 | 다우 아그로사이언시즈 엘엘씨 | 이식 유전자 식물 세포들로부터 유래된 안정한 면역예방적및 치료적 조성물들 및 생산방법 |
| CA2529647C (en) | 2003-06-16 | 2013-08-13 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
| US8592197B2 (en) | 2003-07-11 | 2013-11-26 | Novavax, Inc. | Functional influenza virus-like particles (VLPs) |
| CN1560227A (zh) * | 2004-02-25 | 2005-01-05 | 福建师范大学 | 雨生红球藻原生质体制备与再生技术 |
| CN101065145B (zh) | 2004-08-13 | 2010-12-15 | 印度科学工业研究所 | 嵌合g蛋白基狂犬疫苗 |
| US9155483B2 (en) | 2004-12-03 | 2015-10-13 | The Invention Science Fund I, Llc | Vision modification with reflected image |
| JP5343212B2 (ja) * | 2005-03-15 | 2013-11-13 | ヴェレニウム コーポレイション | セルラーゼ、それらをコードする核酸、並びにそれらを作製及び使用する方法 |
| CN101166827B (zh) | 2005-04-29 | 2013-09-04 | 开普敦大学 | 在植物中表达蛋白质 |
| CN100410378C (zh) | 2005-05-09 | 2008-08-13 | 中国农业科学院生物技术研究所 | 编码禽流感血凝素的基因及其植物表达载体和应用 |
| MX2008000097A (es) * | 2005-06-24 | 2008-03-19 | Bayer Bioscience Nv | Metodos para alterar la reactividad de las paredes de las celulas vegetales. |
| EP1909829A4 (en) | 2005-07-19 | 2009-11-11 | Dow Global Technologies Inc | RECOMBINANT GRIP VACCINES |
| US7871626B2 (en) | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| AU2006304640B2 (en) | 2005-10-18 | 2012-10-11 | Novavax, Inc. | Functional influenza virus like particles (VLPs) |
| EP2360175B1 (en) | 2005-11-22 | 2014-07-16 | Novartis Vaccines and Diagnostics, Inc. | Norovirus and Sapovirus virus-like particles (VLPs) |
| KR20080106433A (ko) | 2006-02-13 | 2008-12-05 | 프라운호퍼 유에스에이, 인코포레이티드 | 인플루엔자 항원, 백신 조성물 및 관련 방법 |
| EP2010210A4 (en) | 2006-04-21 | 2010-07-21 | Dow Agrosciences Llc | VACCINE AGAINST BIRD FLUID AND METHOD OF APPLICATION THEREFOR |
| WO2007130327A2 (en) | 2006-05-01 | 2007-11-15 | Technovax, Inc. | Influenza virus-like particle (vlp) compositions |
| US9511134B2 (en) | 2006-05-18 | 2016-12-06 | Epimmune Inc. | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| WO2007135480A1 (en) | 2006-05-22 | 2007-11-29 | Plant Bioscience Limited | Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants |
| US20070286873A1 (en) | 2006-05-23 | 2007-12-13 | Williams John V | Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor |
| JP5188510B2 (ja) | 2007-01-17 | 2013-04-24 | ラーナー・メディカル・デバイセズ・インコーポレイテッド | 光ファイバー式の光線療法装置 |
| US7730950B2 (en) | 2007-01-19 | 2010-06-08 | Halliburton Energy Services, Inc. | Methods for treating intervals of a subterranean formation having variable permeability |
| RU2499053C2 (ru) | 2007-06-15 | 2013-11-20 | Медикаго Инк. | Способ синтеза белка с модифицированным профилем n-гликозилирования в растениях |
| KR100964462B1 (ko) | 2007-07-10 | 2010-06-16 | 성균관대학교산학협력단 | 형질전환 식물 유래의 조류독감 바이러스 백신 및 그 제조방법 |
| CA2615372A1 (en) | 2007-07-13 | 2009-01-13 | Marc-Andre D'aoust | Influenza virus-like particles (vlps) comprising hemagglutinin |
| RU2358981C2 (ru) * | 2007-08-07 | 2009-06-20 | Центр "Биоинженерия" Российской Академии Наук | Универсальная вакцина против вируса гриппа птиц |
| US20110059130A1 (en) | 2007-08-20 | 2011-03-10 | Fraunhofer Usa, Inc. | Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods |
| CN101422128B (zh) * | 2007-10-29 | 2011-06-08 | 中国水产科学研究院黄海水产研究所 | 马尾藻原生质体的分离和再生 |
| CN101978066A (zh) | 2007-11-27 | 2011-02-16 | 麦迪卡格公司 | 表达血凝素之转基因植物中生产的重组流感病毒样颗粒(vlp) |
| EA201001064A1 (ru) | 2007-12-28 | 2011-02-28 | Юнилевер Н.В. | Способ извлечения аромата из чая |
| US8799801B2 (en) | 2008-01-16 | 2014-08-05 | Qualcomm Incorporated | Interactive ticker |
| EA034733B1 (ru) | 2008-01-21 | 2020-03-13 | Медикаго Инк. | Нуклеиновая кислота для увеличенной экспрессии гемагглютинина вируса гриппа в растении и ее применение |
| PT2294202E (pt) | 2008-07-08 | 2015-10-09 | Medicago Inc | Antigénios gripais recombinantes solúveis |
| CN101626276A (zh) | 2008-07-10 | 2010-01-13 | 华为技术有限公司 | 广告替换方法、装置及系统 |
| ES2593277T3 (es) | 2008-07-18 | 2016-12-07 | Medicago Inc. | Nuevo epítopo de inmunización contra el virus de la influenza |
| CA2736796A1 (en) | 2008-08-27 | 2010-03-04 | Arizona Board Of Regents For And On Behalf Of Arizona State University | A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants |
| US20100167376A1 (en) * | 2008-10-06 | 2010-07-01 | Genvault Corporation | Methods for providing cellular lysates from cell wall-containing samples |
| WO2010077712A1 (en) | 2008-12-09 | 2010-07-08 | Novavax, Inc. | Bovine respiratory syncytial virus virus-like particle (vlps) |
| WO2010088411A2 (en) | 2009-01-30 | 2010-08-05 | Adlyfe, Inc. | Conformationally dynamic peptides |
| CA3018494C (en) | 2009-06-10 | 2021-12-07 | Nono Inc. | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| KR20230098713A (ko) | 2009-06-10 | 2023-07-04 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| NZ597401A (en) | 2009-06-24 | 2013-09-27 | Medicago Inc | Chimeric influenza virus-like particles comprising hemagglutinin |
| PL2480658T3 (pl) * | 2009-09-22 | 2017-12-29 | Medicago Inc. | Sposób otrzymywania VLP pochodzenia roślinnego |
| JP6025214B2 (ja) | 2010-11-04 | 2016-11-16 | メディカゴ インコーポレイテッド | 植物発現系 |
| HUE034247T2 (en) | 2010-11-05 | 2018-02-28 | Novavax Inc | Rabies glycoprotein virus-like particles (VLP-K) |
| TWI526539B (zh) | 2010-12-22 | 2016-03-21 | 苜蓿股份有限公司 | 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp |
| TWI620816B (zh) * | 2011-03-23 | 2018-04-11 | 苜蓿股份有限公司 | 植物衍生蛋白回收方法 |
-
2010
- 2010-09-21 PL PL10818190T patent/PL2480658T3/pl unknown
- 2010-09-21 DK DK10818191.8T patent/DK2480560T3/en active
- 2010-09-21 MY MYPI2012001251A patent/MY164704A/en unknown
- 2010-09-21 BR BR112012006414-2A patent/BR112012006414B1/pt active IP Right Grant
- 2010-09-21 SG SG2012014718A patent/SG178947A1/en unknown
- 2010-09-21 CN CN201710164586.9A patent/CN107129973A/zh active Pending
- 2010-09-21 SI SI201031656T patent/SI2480560T1/en unknown
- 2010-09-21 SG SG2012014254A patent/SG178918A1/en unknown
- 2010-09-21 TR TR2018/03560T patent/TR201803560T4/tr unknown
- 2010-09-21 CN CN201710005957.9A patent/CN107090021A/zh active Pending
- 2010-09-21 DK DK18157629.9T patent/DK3354657T3/da active
- 2010-09-21 MX MX2012003373A patent/MX2012003373A/es active IP Right Grant
- 2010-09-21 HU HUE10818190A patent/HUE036776T2/hu unknown
- 2010-09-21 PT PT181576299T patent/PT3354657T/pt unknown
- 2010-09-21 BR BR112012006415A patent/BR112012006415B1/pt active IP Right Grant
- 2010-09-21 AU AU2010300033A patent/AU2010300033B2/en active Active
- 2010-09-21 PT PT108181900T patent/PT2480658T/pt unknown
- 2010-09-21 KR KR1020127009357A patent/KR101773431B1/ko active IP Right Grant
- 2010-09-21 MY MYPI2012001248A patent/MY158475A/en unknown
- 2010-09-21 HU HUE18157629A patent/HUE058165T2/hu unknown
- 2010-09-21 NO NO10818190A patent/NO2480658T3/no unknown
- 2010-09-21 HU HUE10818191A patent/HUE038557T2/hu unknown
- 2010-09-21 CA CA2772964A patent/CA2772964C/en active Active
- 2010-09-21 CN CN2010800423364A patent/CN102549008A/zh active Pending
- 2010-09-21 AU AU2010300034A patent/AU2010300034B2/en active Active
- 2010-09-21 NZ NZ598508A patent/NZ598508A/en unknown
- 2010-09-21 KR KR1020187005775A patent/KR20180026562A/ko not_active Application Discontinuation
- 2010-09-21 SI SI201032108T patent/SI3354657T1/sl unknown
- 2010-09-21 CN CN2010800423330A patent/CN102549148A/zh active Pending
- 2010-09-21 JP JP2012530059A patent/JP5554414B2/ja active Active
- 2010-09-21 IN IN2637DEN2012 patent/IN2012DN02637A/en unknown
- 2010-09-21 PL PL18157629T patent/PL3354657T3/pl unknown
- 2010-09-21 RU RU2012115996/10A patent/RU2567012C2/ru active
- 2010-09-21 WO PCT/CA2010/001488 patent/WO2011035422A1/en active Application Filing
- 2010-09-21 JP JP2012530060A patent/JP5551780B2/ja active Active
- 2010-09-21 ES ES10818190.0T patent/ES2642631T3/es active Active
- 2010-09-21 EP EP10818190.0A patent/EP2480658B1/en active Active
- 2010-09-21 ES ES18157629T patent/ES2911037T3/es active Active
- 2010-09-21 HR HRP20220478TT patent/HRP20220478T1/hr unknown
- 2010-09-21 EP EP10818191.8A patent/EP2480560B1/en active Active
- 2010-09-21 PL PL10818191T patent/PL2480560T3/pl unknown
- 2010-09-21 KR KR1020127010044A patent/KR20120093223A/ko not_active Application Discontinuation
- 2010-09-21 NZ NZ598481A patent/NZ598481A/en unknown
- 2010-09-21 KR KR1020197012547A patent/KR102115226B1/ko active IP Right Grant
- 2010-09-21 ES ES10818191.8T patent/ES2662778T3/es active Active
- 2010-09-21 SI SI201031558T patent/SI2480658T1/sl unknown
- 2010-09-21 PT PT108181918T patent/PT2480560T/pt unknown
- 2010-09-21 CA CA2772962A patent/CA2772962C/en active Active
- 2010-09-21 MX MX2012003372A patent/MX2012003372A/es active IP Right Grant
- 2010-09-21 EP EP18157629.9A patent/EP3354657B1/en active Active
- 2010-09-21 WO PCT/CA2010/001489 patent/WO2011035423A1/en active Application Filing
- 2010-09-21 IN IN2591DEN2012 patent/IN2012DN02591A/en unknown
- 2010-09-21 DK DK10818190.0T patent/DK2480658T3/da active
- 2010-09-21 RU RU2012115661/10A patent/RU2579903C2/ru active
- 2010-09-21 NO NO10818191A patent/NO2480560T3/no unknown
- 2010-09-21 US US13/497,767 patent/US11833200B2/en active Active
- 2010-09-21 US US13/497,757 patent/US11826419B2/en active Active
- 2010-09-22 AR ARP100103458A patent/AR078432A1/es unknown
- 2010-09-22 AR ARP100103460A patent/AR078433A1/es unknown
-
2012
- 2012-02-29 IL IL218393A patent/IL218393A0/en unknown
- 2012-03-01 IL IL218422A patent/IL218422B/en active IP Right Grant
- 2012-04-18 ZA ZA2012/02836A patent/ZA201202836B/en unknown
- 2012-04-18 ZA ZA2012/02835A patent/ZA201202835B/en unknown
-
2017
- 2017-10-16 HR HRP20171564TT patent/HRP20171564T1/hr unknown
-
2018
- 2018-01-31 IL IL257261A patent/IL257261B/en active IP Right Grant
- 2018-03-27 HR HRP20180509TT patent/HRP20180509T1/hr unknown
-
2019
- 2019-11-14 IL IL270661A patent/IL270661B/en unknown